AbCellera Biologics (NasdaqGS:ABCL) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Company ParticipantsCarl Hansen - CEONone - Company RepresentativeMalcolm Hoffman - Senior BioPharma Equity Research AssociateAndrew Booth - CFONone - Company RepresentativeTryn Stimart - Chief Legal and Compliance OfficerConference Call ParticipantsSteven Dechert - AnalystFaisal Khurshid - Senior Research AnalystAndrea Newkirk - AnalystOperatorGood afternoon, and welcome to AbCellera's Third Quarter 2025 Business Update ...

AbCellera Biologics (NasdaqGS:ABCL) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker2Good afternoon, and welcome to AbCellera's Third Quarter 2025 Business Update Conference Call. My name is Cameron, and I'll facilitate the audio portion of today's interactive broadcast. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end. If you would like to ask a question, please press star followed by one on your telephone keypad, and i ...